Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic?

Saved in:
Bibliographic Details
Main Authors: Dennis Bourdette, Lindsey Wooliscroft
Format: Article
Language:English
Published: Elsevier 2024-07-01
Series:Neurotherapeutics
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1878747924000722
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850265163821744128
author Dennis Bourdette
Lindsey Wooliscroft
author_facet Dennis Bourdette
Lindsey Wooliscroft
author_sort Dennis Bourdette
collection DOAJ
format Article
id doaj-art-e731b430f1514cb9a99d45773405e234
institution OA Journals
issn 1878-7479
language English
publishDate 2024-07-01
publisher Elsevier
record_format Article
series Neurotherapeutics
spelling doaj-art-e731b430f1514cb9a99d45773405e2342025-08-20T01:54:30ZengElsevierNeurotherapeutics1878-74792024-07-01214e0038610.1016/j.neurot.2024.e00386Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic?Dennis Bourdette0Lindsey Wooliscroft1Department of Neurology, Oregon Health & Science University, Portland, OR 97239, USA; Corresponding author.Department of Neurology, Oregon Health & Science University, Portland, OR 97239, USA; Neurology Service, Portland VA Health Care System, Portland, OR 97239, USAhttp://www.sciencedirect.com/science/article/pii/S1878747924000722RemyelinationMultiple sclerosisOPCOligodendrocytesIn vitro
spellingShingle Dennis Bourdette
Lindsey Wooliscroft
Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic?
Neurotherapeutics
Remyelination
Multiple sclerosis
OPC
Oligodendrocytes
In vitro
title Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic?
title_full Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic?
title_fullStr Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic?
title_full_unstemmed Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic?
title_short Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic?
title_sort developing drugs that promote remyelination is our in vitro screening approach too simplistic
topic Remyelination
Multiple sclerosis
OPC
Oligodendrocytes
In vitro
url http://www.sciencedirect.com/science/article/pii/S1878747924000722
work_keys_str_mv AT dennisbourdette developingdrugsthatpromoteremyelinationisourinvitroscreeningapproachtoosimplistic
AT lindseywooliscroft developingdrugsthatpromoteremyelinationisourinvitroscreeningapproachtoosimplistic